Trial · NCT00007345
Adverse events414
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 414
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Peripheral T-cell Lymphoma (PTCL) | 38 | 47 | 151 |
| other | Anemia | Blood and lymphatic system disorders | Cutaneous T-cell Lymphoma (CTCL) | 53 | 84 | 166 |
| other | Anorexia | Gastrointestinal disorders | Peripheral T-cell Lymphoma (PTCL) | 31 | 47 | 124 |
| other | Anorexia | Gastrointestinal disorders | Cutaneous T-cell Lymphoma (CTCL) | 37 | 84 | 79 |
| other | Constipation | Gastrointestinal disorders | Peripheral T-cell Lymphoma (PTCL) | 17 | 47 | 29 |
| other | Constipation | Gastrointestinal disorders | Cutaneous T-cell Lymphoma (CTCL) | 33 | 84 | 61 |
| other | Fatigue | General disorders | Peripheral T-cell Lymphoma (PTCL) | 34 | 47 | 129 |
| other | Fatigue | General disorders | Cutaneous T-cell Lymphoma (CTCL) | 68 | 84 | 194 |
| other | Headache | Nervous system disorders | Peripheral T-cell Lymphoma (PTCL) | 17 | 47 | 32 |
| other | Headache | Nervous system disorders | Cutaneous T-cell Lymphoma (CTCL) | 18 | 84 | 33 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Peripheral T-cell Lymphoma (PTCL) | 28 | 47 | 127 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Cutaneous T-cell Lymphoma (CTCL) | 33 | 84 | 109 |
| other | Hypokalemia | Metabolism and nutrition disorders | Peripheral T-cell Lymphoma (PTCL) | 14 | 47 | 19 |
| other | Hypokalemia | Metabolism and nutrition disorders | Cutaneous T-cell Lymphoma (CTCL) | 14 | 84 | 35 |
| other | Hypermagnesemia | Metabolism and nutrition disorders | Peripheral T-cell Lymphoma (PTCL) | 11 | 47 | 67 |
| other | Hypermagnesemia | Metabolism and nutrition disorders | Cutaneous T-cell Lymphoma (CTCL) | 21 | 84 | 71 |
| other | Hyperuricemia | Metabolism and nutrition disorders | Peripheral T-cell Lymphoma (PTCL) | 16 | 47 | 86 |
| other | Hyperuricemia | Metabolism and nutrition disorders | Cutaneous T-cell Lymphoma (CTCL) | 25 | 84 | 71 |
| other | Hyponatremia | Metabolism and nutrition disorders | Peripheral T-cell Lymphoma (PTCL) | 15 | 47 | 27 |
| other | Hyponatremia | Metabolism and nutrition disorders | Cutaneous T-cell Lymphoma (CTCL) | 14 | 84 | 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00007345/events